Tai Ji Quan for the aging cancer survivor: Mitigating the accelerated development of disability, falls, and cardiovascular disease from cancer treatment
被引量：6
1National Cancer Institute. SEER Cancer Statistics Review,1975-2007[OL].http://seer.cancer.gov/archive/csr/1975_2007/,2010.
2de Moor JS,Mariotto AB,Parry C,Alfano CM Padgett L Kent EE. Cancer survivors in the United States:prevalence across the survivorship trajectory and implications for care[J].Cancer Epidemiology Biomarkers & Prevention,2013.561-570.
3Institute of Medicine. Delivering high-quality cancer care:charting a new course for a system in crisis[M].Washington,DC:The National Academies Press,2013.
4Courneya KS,Vallance JK,McNeely ML,Karvinen KH Peddle C J Mackey JR. Exercise issues in older cancer survivors[J].Critical Reviews in Oncology/Hematology,2004.249-261.
5Mandelblatt J,Figueiredo M,Cullen J. Outcomes and quality of life following breast cancer treatment in older women:when,why,how much,and what do women want[J].Health and Quality of Life Outcomes,2003.45.
6Sanders JL,Fitzpatrick AL,Boudreau RM,Arnold AM Aviv A Kimura M. Leukocyte telomere length is associated with noninvasively measured age-related disease:the Cardiovascular Health Study[J].Journal of Gerontology Series A-Biological Sciences And Medical Sciences,2012.409-416.
7Willeit P,Willeit J,Brandst(a)tter A,Ehrlenbach S Mayr A Gasperi A. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk[J].Arteriosclerosis Thrombosis and Vasoular Biology,2010.1649-1656.
8Hannun YA. Apoptosis and the dilemma of cancer chemotherapy[J].Blood,1997.1845-1853.
9Li P,Hou M,Lou F,Bj(o)rkholm M Xu D. Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells[J].International Journal of Biochemistry and Cell Biology,2012.1531-1540.
10Maccormick RE. Possible acceleration of aging by adjuvant chemotherapy:a cause of early onset frailty[J].Medical Hypotheses,2006.212-215.
